VIVITROL
Generic Name for VIVITROL
Naltrexone 380mg/vial; ext-rel susp for IM inj.
Legal Classification:
Rx
Pharmacological Class for VIVITROL
Opioid antagonist.
Manufacturer of VIVITROL
Alkermes
|
Indications for VIVITROL
Alcohol dependence in patients who are able to abstain from alcohol in an outpatient setting, in conjunction with psychosocial support (eg, counseling or group therapy).
Adult dose for VIVITROL
Give by IM inj into alternating buttocks. 380mg once every 4 weeks.
Children's dosing for VIVITROL
Not recommended.
Contraindications for VIVITROL
Concomitant opioids. Current physiologic opioid dependence. Acute opiate withdrawal. Failed naloxone challenge test. Positive urine test for opioids. Acute hepatitis. Liver failure.
Precautions for VIVITROL
Active liver disease (monitor closely). Discontinue if hepatitis develops. Consider naloxone challenge test before treating to exclude recent (7–10 days) opioid use. Moderate to severe renal dysfunction. Coagulation disorders. Risk of eosinophilic pneumonia; follow-up if respiratory symptoms occur. Monitor for depression and/or suicidality. Advise patient of reduced post-treatment opioid tolerance and of danger of attempting to overcome opioid blockade; advise use of medication alert documentation. Elderly. Pregnancy (Cat.C). Nursing mothers: not recommended.
Interactions for VIVITROL
See Contraindications. Antagonizes opioids (eg, antitussives, antidiarrheals, analgesics); use non-opioids, and/or anesthesia if pain management is necessary. May interfere with urine opioid tests.
Adverse Reactions for VIVITROL
GI upset, fatigue, headache, dizziness, decreased appetite, inj site reactions (may be serious; eg, induration, cellulitis, hematoma, abscess, sterile abscess, necrosis), hepatotoxicity (overdosage); rare: allergic (eosinophilic) pneumonia.
How is VIVITROL supplied?
Vial—1 (w. supplies)
Related Disease:
Alcoholism